Home › Companies › EDITAS MEDICINE INC. › 2023-2024
Compiled from SEC Form N-PX filings and EDITAS MEDICINE INC.’s Form 8-K, filed May 31, 2024 (Item 5.07 on EDGAR). Page generated October 25, 2026.
Meeting of May 30, 2024: 5 items on EDITAS MEDICINE INC.’s Form 8-K, filed May 31, 2024: 2 approved · 3 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore EDITAS MEDICINE INC. in the interactive database Compare manager voting policies
These tallies are EDITAS MEDICINE INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 31, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Meeta Chatterjee, Ph.D. | 32,769,825 | -- | -- | 8,815,678 | 17,765,319 | 79% | Not verified | — |
| Elect Director: Andrew Hirsch | 32,759,650 | -- | -- | 8,825,853 | 17,765,319 | 79% | Not verified | — |
| Elect Director: Gilmore O'Neill, M.B. | 32,909,172 | -- | -- | 8,676,331 | 17,765,319 | 79% | Not verified | — |
| 2. The compensation paid to its named executive officers | 38,609,828 | 2,769,887 | 205,788 | -- | 17,765,319 | 93% | Approved | — |
| 3. The selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the current fiscal year | 57,952,408 | 362,117 | 1,036,297 | -- | 0 | 99.3% | Approved | — |
Source: EDITAS MEDICINE INC., Form 8-K, filed with the SEC on May 31, 2024 — read the filing on EDGAR.
Each item below shows how the 286 asset managers that disclosed a EDITAS MEDICINE INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
79% Majority: yes · of votes cast
Description as filed by funds: Election of three Class II Directors, each to serve until the 2027 Annual Meeting of Stockholders: Andrew Hirsch
EDITAS MEDICINE INC.’s own tally for this item (“Elect Director: Andrew Hirsch”): 32,759,650 for, 8,825,853 withheld, per its Form 8-K filed May 31, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 79% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 57 asset managers below reported 19,301,339 for, 3,544,425 withheld, 83,576 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,440,666 | 0 | 0 | 0 | For |
| State Street | 5,754,847 | 0 | 0 | 84,150 | For |
| BlackRock | 1,799,371 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 1,668,990 | Withhold |
| TIAA | 1,003,672 | 0 | 0 | 0 | For |
| Charles Schwab | 856,095 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 633,402 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 520,168 | Withhold |
| Fidelity | 293,368 | 0 | 0 | 0 | For |
| Equitable | 124,737 | 0 | 0 | 81,300 | Mixed |
| Global X | 185,398 | 0 | 0 | 0 | For |
| SEI | 158,118 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 145,221 | Withhold |
| Neuberger Berman | 137,826 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 125,434 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 111,152 | Withhold |
| Jackson National | 71,043 | 0 | 20,635 | 0 | Mixed |
| Northern Trust | 79,337 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 78,471 | Withhold |
| Lincoln Financial | 70,938 | 0 | 0 | 3,993 | Mixed |
| Bridge Builder Trust | 33,545 | 0 | 23,960 | 0 | Mixed |
| AIG/SunAmerica | 0 | 0 | 0 | 40,870 | Withhold |
| Pacific Life | 32,318 | 0 | 0 | 0 | For |
| Listed Funds Trust | 0 | 0 | 0 | 31,670 | Withhold |
| Prudential/PGIM | 31,295 | 0 | 0 | 0 | For |
Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.
Combines 3 wordings of this item as funds reported it.
79% Majority: yes · of votes cast
Description as filed by funds: Election of three Class II Directors, each to serve until the 2027 Annual Meeting of Stockholders: Gilmore O'Neill, M.B.
EDITAS MEDICINE INC.’s own tally for this item (“Elect Director: Gilmore O'Neill, M.B.”): 32,909,172 for, 8,676,331 withheld, per its Form 8-K filed May 31, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 79% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 57 asset managers below reported 19,382,639 for, 3,463,125 withheld, 83,576 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,440,666 | 0 | 0 | 0 | For |
| State Street | 5,754,847 | 0 | 0 | 84,150 | For |
| BlackRock | 1,799,371 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 1,668,990 | Withhold |
| TIAA | 1,003,672 | 0 | 0 | 0 | For |
| Charles Schwab | 856,095 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 633,402 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 520,168 | Withhold |
| Fidelity | 293,368 | 0 | 0 | 0 | For |
| Equitable | 206,037 | 0 | 0 | 0 | For |
| Global X | 185,398 | 0 | 0 | 0 | For |
| SEI | 158,118 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 145,221 | Withhold |
| Neuberger Berman | 137,826 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 125,434 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 111,152 | Withhold |
| Jackson National | 71,043 | 0 | 20,635 | 0 | Mixed |
| Northern Trust | 79,337 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 78,471 | Withhold |
| Lincoln Financial | 70,938 | 0 | 0 | 3,993 | Mixed |
| Bridge Builder Trust | 33,545 | 0 | 23,960 | 0 | Mixed |
| AIG/SunAmerica | 0 | 0 | 0 | 40,870 | Withhold |
| Pacific Life | 32,318 | 0 | 0 | 0 | For |
| Listed Funds Trust | 0 | 0 | 0 | 31,670 | Withhold |
| Prudential/PGIM | 31,295 | 0 | 0 | 0 | For |
Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.
Combines 3 wordings of this item as funds reported it.
79% Majority: yes · of votes cast
Description as filed by funds: Election of three Class II Directors, each to serve until the 2027 Annual Meeting of Stockholders: Meeta Chatterjee, Ph.D.
EDITAS MEDICINE INC.’s own tally for this item (“Elect Director: Meeta Chatterjee, Ph.D.”): 32,769,825 for, 8,815,678 withheld, per its Form 8-K filed May 31, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 79% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 57 asset managers below reported 19,301,339 for, 3,544,425 withheld, 83,576 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,440,666 | 0 | 0 | 0 | For |
| State Street | 5,754,847 | 0 | 0 | 84,150 | For |
| BlackRock | 1,799,371 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 1,668,990 | Withhold |
| TIAA | 1,003,672 | 0 | 0 | 0 | For |
| Charles Schwab | 856,095 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 633,402 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 520,168 | Withhold |
| Fidelity | 293,368 | 0 | 0 | 0 | For |
| Equitable | 124,737 | 0 | 0 | 81,300 | Mixed |
| Global X | 185,398 | 0 | 0 | 0 | For |
| SEI | 158,118 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 145,221 | Withhold |
| Neuberger Berman | 137,826 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 125,434 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 111,152 | Withhold |
| Jackson National | 71,043 | 0 | 20,635 | 0 | Mixed |
| Northern Trust | 79,337 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 78,471 | Withhold |
| Lincoln Financial | 70,938 | 0 | 0 | 3,993 | Mixed |
| Bridge Builder Trust | 33,545 | 0 | 23,960 | 0 | Mixed |
| AIG/SunAmerica | 0 | 0 | 0 | 40,870 | Withhold |
| Pacific Life | 32,318 | 0 | 0 | 0 | For |
| Listed Funds Trust | 0 | 0 | 0 | 31,670 | Withhold |
| Prudential/PGIM | 31,295 | 0 | 0 | 0 | For |
Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.
Combines 17 wordings of this item as funds reported it.
93% Approved · of votes cast
Description as filed by funds: To approve, on an advisory basis, the compensation paid to the Company's named executive officers.
EDITAS MEDICINE INC.’s own tally for this item (“2. The compensation paid to its named executive officers”): 38,609,828 for, 2,769,887 against — passed, per its Form 8-K filed May 31, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved, on an advisory basis, the compensation paid to its named executive officers.”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,440,666 | 0 | 0 | 0 | For |
| State Street | 5,838,997 | 0 | 0 | 0 | For |
| BlackRock | 1,799,371 | 0 | 0 | 0 | For |
| Dimensional | 1,668,990 | 0 | 0 | 0 | For |
| TIAA | 1,003,672 | 0 | 0 | 0 | For |
| Charles Schwab | 856,095 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 633,402 | 0 | 0 | 0 | For |
| Goldman Sachs | 520,168 | 0 | 0 | 0 | For |
| Fidelity | 293,368 | 0 | 0 | 0 | For |
| Equitable | 206,037 | 0 | 0 | 0 | For |
| Global X | 185,398 | 0 | 0 | 0 | For |
| SEI | 158,118 | 0 | 0 | 0 | For |
| ProShares | 145,221 | 0 | 0 | 0 | For |
| Neuberger Berman | 137,826 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 125,434 | 0 | 0 | 0 | For |
| American Century | 111,152 | 0 | 0 | 0 | For |
| Jackson National | 91,678 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 0 | 89,803 | 0 | 0 | Against |
| Northern Trust | 79,337 | 0 | 0 | 0 | For |
| Victory Capital | 78,471 | 0 | 0 | 0 | For |
| Lincoln Financial | 74,931 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 57,505 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 40,870 | 0 | 0 | 0 | For |
| Pacific Life | 32,318 | 0 | 0 | 0 | For |
| Listed Funds Trust | 31,670 | 0 | 0 | 0 | For |
Fund voting reports, all 59 managers: 22,902,037 for, 98,048 against, 20,268 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 7,371,900 | 0 | 0 | 0 | For |
| BlackRock | 2,505,728 | 0 | 0 | 0 | For |
| Deep Track Capital, LP | 1,920,429 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 1,126,151 | 0 | 0 | 0 | For |
| Nuveen | 1,013,880 | 0 | 0 | 0 | For |
| JPMorgan | 987,502 | 0 | 0 | 0 | For |
| Woodline Partners LP | 895,000 | 0 | 0 | 0 | For |
| Charles Schwab | 856,095 | 0 | 0 | 0 | For |
| UBS | 3,287 | 700,266 | 0 | 0 | Against |
| MARSHALL WACE, LLP | 0 | 693,855 | 0 | 0 | Against |
| Rafferty Asset Management, LLC | 633,402 | 0 | 0 | 0 | For |
| DE Shaw | 476,805 | 0 | 0 | 0 | For |
| Northern Trust | 428,940 | 2,878 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 343,763 | 0 | 0 | 0 | For |
| Dimensional | 306,871 | 0 | 0 | 0 | For |
| Neuberger Berman | 275,452 | 0 | 0 | 0 | For |
| STIFEL NICOLAUS & CO INC \MO\ | 247,121 | 0 | 0 | 0 | For |
| Two Sigma | 204,233 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 162,341 | 0 | 0 | 0 | For |
| SEI | 161,892 | 0 | 0 | 0 | For |
| Goldman Sachs | 153,165 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 151,912 | 0 | 0 | 0 | For |
| Knott David M Jr | 140,000 | 0 | 0 | 0 | For |
| Citadel | 130,523 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 119,560 | 0 | 0 | 0 | For |
Institutional-manager reports, all 247 managers: 22,251,338 for, 1,592,540 against, 270 abstained, 19,771 not voted. Showing the 25 largest; see all in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.3% Approved · of votes cast
Description as filed by funds: TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2024.
EDITAS MEDICINE INC.’s own tally for this item (“3. The selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the current fiscal year”): 57,952,408 for, 362,117 against — passed, per its Form 8-K filed May 31, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the current fiscal year.”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 60 asset managers below reported 22,990,189 for, 9,916 against, 20,268 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,440,666 | 0 | 0 | 0 | For |
| State Street | 5,829,081 | 9,916 | 0 | 0 | For |
| BlackRock | 1,799,371 | 0 | 0 | 0 | For |
| Dimensional | 1,668,990 | 0 | 0 | 0 | For |
| TIAA | 1,003,672 | 0 | 0 | 0 | For |
| Charles Schwab | 856,095 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 633,402 | 0 | 0 | 0 | For |
| Goldman Sachs | 520,168 | 0 | 0 | 0 | For |
| Fidelity | 293,368 | 0 | 0 | 0 | For |
| Equitable | 206,037 | 0 | 0 | 0 | For |
| Global X | 185,398 | 0 | 0 | 0 | For |
| SEI | 158,118 | 0 | 0 | 0 | For |
| ProShares | 145,221 | 0 | 0 | 0 | For |
| Neuberger Berman | 137,826 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 125,434 | 0 | 0 | 0 | For |
| American Century | 111,152 | 0 | 0 | 0 | For |
| Jackson National | 91,678 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 89,803 | 0 | 0 | 0 | For |
| Northern Trust | 79,337 | 0 | 0 | 0 | For |
| Victory Capital | 78,471 | 0 | 0 | 0 | For |
| Lincoln Financial | 74,931 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 57,505 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 40,870 | 0 | 0 | 0 | For |
| Pacific Life | 32,318 | 0 | 0 | 0 | For |
| Listed Funds Trust | 31,670 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 82,234,951 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 10.26% |
| 2 | State Street | 7.10% |
| 3 | BlackRock | 2.19% |
| 4 | Dimensional | 2.03% |
| 5 | TIAA | 1.22% |
| 6 | Charles Schwab | 1.04% |
| 7 | Direxion Shares ETF Trust | 0.77% |
| 8 | Goldman Sachs | 0.63% |
| 9 | Fidelity | 0.36% |
| 10 | Equitable | 0.25% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | State Street | 8.96% |
| 2 | BlackRock | 3.05% |
| 3 | Deep Track Capital, LP | 2.34% |
| 4 | PICTET ASSET MANAGEMENT SA | 1.37% |
| 5 | Nuveen | 1.23% |
| 6 | JPMorgan | 1.20% |
| 7 | Woodline Partners LP | 1.09% |
| 8 | Charles Schwab | 1.06% |
| 9 | UBS | 0.86% |
| 10 | MARSHALL WACE, LLP | 0.84% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| State Street | 10.65% | 13F |
| BlackRock | 9.75% | 13F |
| Vanguard Group | 8.47% | 13F |
| Deep Track Capital, LP | 6.66% | DEF14A |
| Dimensional Fund Advisors | 3.17% | 13F |
| Millennium Management | 2.72% | 13F |
| Geode Capital | 2.36% | 13F |
| Two Sigma | 1.69% | 13F |
| D.E. Shaw | 1.32% | 13F |
| Morgan Stanley | 1.32% | 13F |
Percentages above are of 82,234,951 shares outstanding, as reported by EDITAS MEDICINE INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from EDITAS MEDICINE INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.
At EDITAS MEDICINE INC.'s shareholder meeting held May 30, 2024, in the 2023-2024 proxy season, 286 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 1,281 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation paid to the Company's named executive… — EDITAS MEDICINE INC.'s filing reports the proposal as approved, with 93% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: EDITAS MEDICINE INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 31, 2024.
EDITAS MEDICINE INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.